Relationship Between Metabolic Syndrome and Polycystic Ovary Syndrome with Special Reference to C-Reactive Protein

被引:1
作者
Alissa, Eman M. [1 ]
Algarni, Samiah A. [1 ]
Khaffji, Azza J. [2 ]
Mansouri, Nisma M. Al [3 ]
机构
[1] King Abdulaziz Univ, Fac Med, Dept Clin Biochem, Jeddah, Saudi Arabia
[2] King Abdulaziz Hosp, Dept Obstet & Gynecol, Jeddah 21589, Saudi Arabia
[3] King Abdulaziz Univ, Fac Med, Obstet & Gynecol Dept, Jeddah, Saudi Arabia
关键词
BMI; CRP; HOMA-IR; WC; WHR; WHtR; IMPAIRED GLUCOSE-TOLERANCE; INSULIN-RESISTANCE; CARDIOVASCULAR RISK; ANDROGEN EXCESS; WOMEN; PREVALENCE; PCOS; OBESITY; INFLAMMATION; ASSOCIATION;
D O I
10.1016/j.jogc.2023.102255
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives: To estimate C -reactive protein (CRP) levels in Saudi women with and without polycystic ovary syndrome (PCOS), and to investigate the associations between CRP and metabolic syndrome (MetS) components. Methods: We randomly recruited 200 women with and without PCOS, between 18 and 38 years, in this age-matched case -control study. Study subjects were allocated to 1 of 4 groups according to the presence or absence of MetS. Interviews were conducted with all participants, and anthropometric measurements and blood samples were obtained for subsequent analysis of biochemical variables. Results: Two-thirds of the study population and all study subjects had central obesity. Fasting insulin and homeostasis model assessment insulin resistance index were significantly higher in PCOS and MetS groups than all other groups ( P < 0.05). CRP levels were significantly higher among women with PCOS than their age-matched controls, regardless of the presence of MetS ( P < 0.05). Body mass index was the only independent predictor of serum high-sensitivity-CRP, accounting for 17% of the variability in circulating levels (b = 0.407; 95% CI 0.248e0.472, P < 0.0001). Conclusions: Obesity and insulin resistance are important risk factors for MetS in PCOS. The presence of MetS in PCOS subjects aggravates the proinflammatory state reflected by CRP levels.
引用
收藏
页数:6
相关论文
共 25 条
[1]   Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome [J].
Apridonidze, T ;
Essah, PA ;
Iuorno, MJ ;
Nestler, JE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (04) :1929-1935
[2]   The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report [J].
Azziz, Ricardo ;
Carmina, Enrico ;
Dewailly, Didier ;
Diamanti-Kandarakis, Evanthia ;
Escobar-Morreale, Hector F. ;
Futterweit, Walter ;
Janssen, Onno E. ;
Legro, Richard S. ;
Norman, Robert J. ;
Taylor, Ann E. ;
Witchel, Selina F. .
FERTILITY AND STERILITY, 2009, 91 (02) :456-488
[3]   Relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism [J].
Carmina, E ;
Rosato, F ;
Jannì, A ;
Rizzo, M ;
Longo, RA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (01) :2-6
[4]   Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome [J].
Chang, J ;
Azziz, R ;
Legro, R ;
Dewailly, D ;
Franks, S ;
Tarlatzis, BC ;
Fauser, B ;
Balen, A ;
Bouchard, P ;
Dahlgren, E ;
Devoto, L ;
Diamanti, E ;
Dunaif, A ;
Filicori, M ;
Homburg, R ;
Ibanez, L ;
Laven, J ;
Magoffin, D ;
Nestler, J ;
Norman, RJ ;
Pasquali, R ;
Pugeat, M ;
Strauss, J ;
Tan, S ;
Taylor, A ;
Wild, R ;
Wild, S ;
Ehrmann, D ;
Lobo, R .
FERTILITY AND STERILITY, 2004, 81 (01) :19-25
[5]  
Chu James W, 2005, Diab Vasc Dis Res, V2, P37, DOI 10.3132/dvdr.2005.004
[6]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[7]   Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk? [J].
Daan, Nadine M. P. ;
Louwers, Yvonne V. ;
Koster, Maria P. H. ;
Eijkemans, Marinus J. C. ;
de Rijke, Yolanda B. ;
Lentjes, Eef W. G. ;
Fauser, Bart C. J. M. ;
Laven, Joop S. E. .
FERTILITY AND STERILITY, 2014, 102 (05) :1444-1451.e3
[8]   INSULIN RESISTANCE - A MULTIFACETED SYNDROME RESPONSIBLE FOR NIDDM, OBESITY, HYPERTENSION, DYSLIPIDEMIA, AND ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE [J].
DEFRONZO, RA ;
FERRANNINI, E .
DIABETES CARE, 1991, 14 (03) :173-194
[9]   Is PCOS an inflammatory process? [J].
Duleba, Antoni J. ;
Dokras, Anuja .
FERTILITY AND STERILITY, 2012, 97 (01) :7-12
[10]   PROFOUND PERIPHERAL INSULIN RESISTANCE, INDEPENDENT OF OBESITY, IN POLYCYSTIC OVARY SYNDROME [J].
DUNAIF, A ;
SEGAL, KR ;
FUTTERWEIT, W ;
DOBRJANSKY, A .
DIABETES, 1989, 38 (09) :1165-1174